2019年 December 12, 2019 Announcement of Licensing Agreement for Ophthalmic Treatment "DW-1001" December 6, 2019 Announcement of the commencement of a domestic Phase I trial of the Janus kinase inhibitor "ROH-201" in the field of ophthalmology [PDF: 143KB] September 4, 2019 Establishment of ROHTO Advanced Research Hong Kong Limited as a Hub for Cutting-edge Research in Hong Kong August 20, 2019 Verifying the effects of secretory components of mesenchymal stem cells on the cornea July 19, 2019 Discovery of a new factor involved in the formation of skin barrier function in atopic dermatitis June 26, 2019 Rohto Pharmaceutical Discovers Extract That Addresses Sagging Skin Around the Eyes May 22, 2019 A new mechanism by which apigenin, a compound found in tropical fruits such as guava, suppresses the activation of microglia, which are involved in retinal inflammation, has been discovered. March 4, 2019 Sony's new material "Triporous™" has been found to be effective in absorbing body odor and capturing bacteria that cause it. February 21, 2019 Developed high-concentration L-ascorbic acid (vitamin C) dissolving and stabilizing technology. Successfully dissolved and stabilized 25% vitamin C. January 24, 2019 Discovery of the effect of tartaric acid, a component of wine, on hair-related cells 12to the next